Department of Pediatrics, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pediatr Infect Dis J. 2010 Apr;29(4):294-300. doi: 10.1097/INF.0b013e3181c2a229.
The heptavalent pneumococcal conjugate vaccine (PCV7) has significantly reduced vaccine-type invasive pneumococcal disease (IPD) in children. An increasing percentage of IPD cases are now caused by nonvaccine serotypes. The purpose of our observational study was to define the epidemiology of pneumococcal disease in Dallas, TX children for 8 years after implementation of PCV7 immunization.
Streptococcus pneumoniae isolates from normally sterile sites were collected at Children's Medical Center of Dallas from January 1, 1999 to December 31, 2008. Incidence of IPD was calculated using inpatient and emergency center admissions to Children's Medical Center of Dallas as the denominator. Isolates were serotyped and penicillin and cefotaxime susceptibilities were determined. Serotype 19A isolates were further characterized by multilocus sequence typing.
Compared with the prevaccine period of 1999-2000, there was a significant reduction in the incidence of IPD from 2002 to 2008 (P < 0.05), although a significant increase in IPD incidence was observed from 2006 to 2008 (P = 0.038). The number of IPD cases caused by serotype 19A increased from 1999 to 2008 (P < 0.001). There were significant increases in penicillin and cefotaxime nonsusceptible 19A isolates during this 10-year period (P < 0.001 and P = 0.004, respectively). The most common sequence type (ST) of the 19A isolates was ST-199 (42.7%). Clonal complex (cc-156) and cc-320 emerged in the period of 2005-2008 as penicillin and cefotaxime resistant 19A strains.
In Dallas, PCV7 immunization reduced significantly the incidence of IPD caused by vaccine-type strains. A significant increase in IPD caused by serotype 19A was observed. The penicillin and cefotaxime nonsusceptible STs, not previously identified in Dallas, have recently become an important cause of IPD.
七价肺炎球菌结合疫苗(PCV7)显著降低了儿童中疫苗型侵袭性肺炎球菌病(IPD)的发病率。现在,越来越多的 IPD 病例是由非疫苗血清型引起的。我们的观察性研究的目的是在达拉斯,TX 儿童在实施 PCV7 免疫接种 8 年后定义肺炎球菌病的流行病学。
1999 年 1 月 1 日至 2008 年 12 月 31 日期间,从达拉斯儿童医疗中心收集正常无菌部位的肺炎链球菌分离株。通过计算儿童医疗中心的住院和急诊中心入院人数来计算 IPD 的发病率。分离株进行血清型分型,并测定青霉素和头孢噻肟的药敏性。进一步对血清型 19A 分离株进行多位点序列分型。
与 1999-2000 年疫苗前时期相比,2002-2008 年 IPD 的发病率显著降低(P<0.05),尽管 2006-2008 年 IPD 的发病率显著增加(P=0.038)。19A 血清型引起的 IPD 病例数从 1999 年增加到 2008 年(P<0.001)。在这 10 年期间,青霉素和头孢噻肟非敏感 19A 分离株的数量显著增加(P<0.001 和 P=0.004)。19A 分离株最常见的序列型(ST)为 ST-199(42.7%)。2005-2008 年期间,克隆复合体(cc-156)和 cc-320 作为青霉素和头孢噻肟耐药 19A 菌株出现。
在达拉斯,PCV7 免疫显著降低了疫苗型菌株引起的 IPD 发病率。观察到血清型 19A 引起的 IPD 显著增加。最近,在达拉斯尚未发现的青霉素和头孢噻肟非敏感 ST 已成为 IPD 的重要原因。